Literature DB >> 20049842

Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

Eric J Jacobs1, Stephen J Chanock, Charles S Fuchs, Andrea Lacroix, Robert R McWilliams, Emily Steplowski, Rachael Z Stolzenberg-Solomon, Alan A Arslan, H Bas Bueno-de-Mesquita, Myron Gross, Kathy Helzlsouer, Gloria Petersen, Wei Zheng, Ilir Agalliu, Naomi E Allen, Laufey Amundadottir, Marie-Christine Boutron-Ruault, Julie E Buring, Federico Canzian, Sandra Clipp, Miren Dorronsoro, J Michael Gaziano, Edward L Giovannucci, Susan E Hankinson, Patricia Hartge, Robert N Hoover, David J Hunter, Kevin B Jacobs, Mazda Jenab, Peter Kraft, Charles Kooperberg, Shannon M Lynch, Malin Sund, Julie B Mendelsohn, Tracy Mouw, Christina C Newton, Kim Overvad, Domenico Palli, Petra H M Peeters, Aleksandar Rajkovic, Xiao-Ou Shu, Gilles Thomas, Geoffrey S Tobias, Dimitrios Trichopoulos, Jarmo Virtamo, Jean Wactawski-Wende, Brian M Wolpin, Kai Yu, Anne Zeleniuch-Jacquotte.   

Abstract

A family history of pancreatic cancer has consistently been associated with increased risk of pancreatic cancer. However, uncertainty remains about the strength of this association. Results from previous studies suggest a family history of select cancers (i.e., ovarian, breast and colorectal) could also be associated, although not as strongly, with increased risk of pancreatic cancer. We examined the association between a family history of 5 types of cancer (pancreas, prostate, ovarian, breast and colorectal) and risk of pancreatic cancer using data from a collaborative nested case-control study conducted by the Pancreatic Cancer Cohort Consortium. Cases and controls were from cohort studies from the United States, Europe and China, and a case-control study from the Mayo Clinic. Analyses of family history of pancreatic cancer included 1,183 cases and 1,205 controls. A family history of pancreatic cancer in a parent, sibling or child was associated with increased risk of pancreatic cancer [multivariate-adjusted odds ratios (ORs) = 1.76, 95% confidence interval (CI) = 1.19-2.61]. A family history of prostate cancer was also associated with increased risk (OR = 1.45, 95% CI = 1.12-1.89). There were no statistically significant associations with a family history of ovarian cancer (OR = 0.82, 95% CI = 0.52-1.31), breast cancer (OR = 1.21, 95% CI = 0.97-1.51) or colorectal cancer (OR = 1.17, 95% CI = 0.93-1.47). Our results confirm a moderate sized association between a family history of pancreatic cancer and risk of pancreatic cancer and also provide evidence for an association with a family history of prostate cancer worth further study.

Entities:  

Mesh:

Year:  2010        PMID: 20049842      PMCID: PMC2926939          DOI: 10.1002/ijc.25148

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC).

Authors:  Manami Inoue; Kazuo Tajima; Toshiro Takezaki; Nobuyuki Hamajima; Kaoru Hirose; Hidemi Ito; Suketami Tominaga
Journal:  Int J Epidemiol       Date:  2003-04       Impact factor: 7.196

2.  Implementation of the Women's Health Initiative study design.

Authors:  Garnet L Anderson; Joann Manson; Robert Wallace; Bernedine Lund; Dallas Hall; Scott Davis; Sally Shumaker; Ching-Yun Wang; Evan Stein; Ross L Prentice
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

3.  Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.

Authors:  Kari Hemminki; Xinjun Li
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

4.  Familial risk of pancreatic cancer.

Authors:  M Schenk; A G Schwartz; E O'Neal; M Kinnard; J K Greenson; J P Fryzek; G S Ying; D H Garabrant
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 13.506

5.  Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.

Authors:  G Lal; G Liu; B Schmocker; P Kaurah; H Ozcelik; S A Narod; M Redston; S Gallinger
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

6.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

7.  Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas.

Authors:  Parviz Ghadirian; Geoffrey Liu; Steven Gallinger; Beverly Schmocker; Anne-Josee Paradis; Geeta Lal; Jean-Sebastien Brunet; William D Foulkes; Steven A Narod
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

Review 8.  Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.

Authors:  Harvey J Murff; David R Spigel; Sapna Syngal
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

9.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

10.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

View more
  47 in total

1.  Genetic susceptibility to pancreatic cancer.

Authors:  Alison P Klein
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.

Authors:  Brian M Wolpin; Peter Kraft; Jihye Kim; Chen Yuan; Ana Babic; Ying Bao; Clary B Clish; Michael N Pollak; Laufey T Amundadottir; Alison P Klein; Rachael Z Stolzenberg-Solomon; Pari V Pandharipande; Lauren K Brais; Marisa W Welch; Kimmie Ng; Edward L Giovannucci; Howard D Sesso; JoAnn E Manson; Meir J Stampfer; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-22       Impact factor: 4.254

Review 3.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

Review 4.  Familial pancreatic cancer.

Authors:  Gloria M Petersen
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

5.  Association between allergies and risk of pancreatic cancer.

Authors:  Michelle Cotterchio; Elizabeth Lowcock; Thomas J Hudson; Celia Greenwood; Steven Gallinger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-19       Impact factor: 4.254

Review 6.  Identifying people at a high risk of developing pancreatic cancer.

Authors:  Alison P Klein
Journal:  Nat Rev Cancer       Date:  2012-12-06       Impact factor: 60.716

7.  Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.

Authors:  Erica J Childs; Kari G Chaffee; Steven Gallinger; Sapna Syngal; Ann G Schwartz; Michele L Cote; Melissa L Bondy; Ralph H Hruban; Stephen J Chanock; Robert N Hoover; Charles S Fuchs; David N Rider; Laufey T Amundadottir; Rachael Stolzenberg-Solomon; Brian M Wolpin; Harvey A Risch; Michael G Goggins; Gloria M Petersen; Alison P Klein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-16       Impact factor: 4.254

8.  A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study.

Authors:  Shannon M Lynch; Jacqueline M Major; Richard Cawthon; Stephanie J Weinstein; Jarmo Virtamo; Qing Lan; Nathaniel Rothman; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Int J Cancer       Date:  2013-06-14       Impact factor: 7.396

Review 9.  Familial Pancreatic Adenocarcinoma.

Authors:  Gloria M Petersen
Journal:  Hematol Oncol Clin North Am       Date:  2015-06-09       Impact factor: 3.722

10.  Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study.

Authors:  Melissa A Austin; Elena Kuo; Stephen K Van Den Eeden; Margaret T Mandelson; Teresa A Brentnall; Aruna Kamineni; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-21       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.